Capital Development Invest Westlake Village 
socalTECH
SEPTEMBER 5, 2018
Westlake Village BioPartners , a brand new venture capital fund focused on the life sciences, said on Wednesday that it has launched a new, $320 investment fund aimed at early stage companies. general partner at Kleiner Perkins and former chief medical officer and head of global development at Amgen, and Sean Harper, M.D.,
socalTECH
FEBRUARY 1, 2022
Westlake Village-based gravity energy storage technology developer Energy Vault announced this morning that it is in a $100M transaction with two companies, Atlas Renewable and China Tianying, which involves a $50M investment subscription and an expansion of a PIPE agreement from $150M to $200M.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
MARCH 15, 2018
Westlake Village-based Pray.com , which develops social networking applications for religious communities, has raised $14M in a Series A funding, the company said this week. The funding was led by TPG Growth, and also included Science Inc. and Greylock Partners.
socalTECH
SEPTEMBER 10, 2021
Westlake Village-based gravity-based energy storage technology developer EnergyVault says it will list on the NYSE, via a merger with a special purpose acqisition company (SPAC), Novus Capital Corporation II. The two said the combined firm will have an implied pro-forma enterprise value of $1.1 and others.
socalTECH
DECEMBER 8, 2022
Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases. a co-founding managing director at Westlake. Dantari has appointed Richard A. Markus, M.D.,
socalTECH
APRIL 25, 2017
Westlake Village-based Sienna Biopharmaceuticals , which is developing medical dermatology and aesthetics treatments, has raised $40M in a Series B funding. David Pyott, plus new investors Fidelity Management & Research Company, certain investment funds advised by Clough Capital Partners L.P.,
Xconomy
SEPTEMBER 5, 2018
Los Angeles has long been in San Francisco’s shadow when it comes to life sciences investment. But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital.
Expert insights. Personalized for you.
100 
Let's personalize your content